Newlink Genetics reported 0 in Interest Expense on Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Agenus AGEN:US $ 13.73M 1.47M
Bristol Myers Squibb BMY:US $ 313M 13M
Eli Lilly And LLY:US $ 81.2M 3.7M
Nektar Therapeutics NKTR:US $ 7.23M 0.3M
Pfizer PFE:US $ 293M 29M
Sarepta Therapeutics SRPT:US $ 16.03M 0.23M
Vascular Biogenics VBLT:US 25K 15K
YTE INCY:US $ 0.68M 0M